Ian Guider

Ian Guider

Ian Guider is Markets Editor of The Sunday Business Post, and leads the paper’s markets coverage. He previously worked with Newstalk, where he was Business Editor and presenter of the station’s daily business show Breakfast Business. Guider has been a business journalist for more than 15 years, working for a number of Irish and international media groups including the Irish Examiner, the Sunday Tribune and Bloomberg, where he was Banking Correspondent.

Ferry companies say compensation ruling puts services in ‘economic peril’

Ferry companies say compensation ruling puts services in ‘economic peril’

Having to pay out to passengers could spell end of links to the continent, firms warn government

State spending tsar criticises Revenue after firm’s €113m tax bill is settled for €10m

State spending tsar criticises Revenue after firm’s €113m tax bill is settled for €10m

The Comptroller & Auditor General’s annual report, released this month, detailed a number of large settlements the taxman entered into in 2018

Donohoe’s strategy looks less prudent as Brexit Day looms

Donohoe’s strategy looks less prudent as Brexit Day looms

The time to prepare for Brexit was long before last week’s budget. Now it may well be too late

Aryzta badly needs a turnaround in its US business with a ‘bumpy road ahead’

Aryzta badly needs a turnaround in its US business with a ‘bumpy road ahead’

Best known in Ireland for its Cuisine de France brand, the company is continuing to sell off assets to pay down debt

Ulster Bank offloads €800m of toxic mortgages

Ulster Bank offloads €800m of toxic mortgages

Pepper Finance buys Project Deenish portfolio of about 3,200 non-performing loans

State resources are plentiful, but it won’t always be so

State resources are plentiful, but it won’t always be so

With a no-deal Brexit looming, it’s vital the state adopts more vigilance when it comes to government departments wasting and misspending taxpayers’ money

Amryt transforms itself with takeover of US pharma firm to develop key drugs

Amryt transforms itself with takeover of US pharma firm to develop key drugs

The chance to advance medicines for rare conditions such as EB, or butterfly skin, spurred the company on to make the acquisition

San Leon takes a €15.5m hit after Providence fails to secure Apec loan

San Leon takes a €15.5m hit after Providence fails to secure Apec loan

San Leon revealed last week that it has taken a further impair charge against its interest in Providence’s Barryroe oil field to the tune of almost $18 million

Linked Finance to offer €300,000 loans for Brexit

Linked Finance to offer €300,000 loans for Brexit

The company said the introduction of 18-month loans would allow small businesses to access credit for things such as insurance premiums, stocking loans or professional subscriptions

Flutter takes gamble on Stars deal

Flutter takes gamble on Stars deal

The all-share merger will see Flutter shareholders control 54 per cent of the combined business, which will look to grow in the United States and extend its position as one of the world’s largest betting companies

WeWork and the magical universe of the unicorns

WeWork and the magical universe of the unicorns

Until recently, venture capitalists were happy to overlook whether their star investments were actually making any money. But, as WeWork has learned, that doesn’t last forever

Convenience food supremo whets its appetite for new acquisitions

Convenience food supremo whets its appetite for new acquisitions

Food giant Greencore plans to ramp up sales of food-on-the-go options such as salads and snacks via strategic takeovers and new partnerships

Central Bank: foreign exchange contracts have trebled to €13bn a day

Central Bank: foreign exchange contracts have trebled to €13bn a day

New information released by the Central Bank shows there has been a substantial increase in the value of interest rate swaps and foreign exchange contracts since 2016

Athyrium fund emerges as Amryt’s largest shareholder

Athyrium fund emerges as Amryt’s largest shareholder

Amryt confirmed last week that it has raised $60 million to buy rare disease drug firm Aegerion

CRH taps Richie Boucher as new chairman

CRH taps Richie Boucher as new chairman

Richie Boucher has returned to the front line of Irish business with his appointment this morning...